Shop Easy Usa Ultram

MONTREAL, QUEBEC (MARKET WIRE) Paladin Labs Inc. (TSX: PLB) and Nycomed Canada Inc., a subsidiary of Nycomed today announced that the companies have entered into a Canadian Co-Promotion Agreement for Tridural(TM) once-daily tramadol. Paladin acquired the Canadian license to Tridural(TM) from Labopharm Inc. (TSX: DDS)(NASDAQ: DDSS) in July 2007 and launched Tridural(TM) in September 2007. (Source: Market Wire - Pharmaceuticals and Biotech)

A new ISO standard will help ensure that spinal disc prostheses meet requirements for wear resistance, particularly important as once implanted these will need to absorb the impact from the body's daily activities for years to come.

Osteopaths from around the world will gather today in London to mark the 10th anniversary of the opening of the UK Statutory Register for Osteopaths at a reception held in the presence of HRH The Prince of Wales.

Centene Corporation (NYSE: CNC) announced an initiative to promote provider participation in the national Back Pain Recognition Program (BPRP) developed by the National Committee for Quality Assurance (NCQA). The BPRP was launched in January 2007 to recognize healthcare providers who deliver top-quality care to patients with low back pain. One in nine Americans suffer from back pain each year; related treatment costs total approximately $91 billion annually.

A recent Journal of the American Medical Association study that found minorities are less likely than whites to receive narcotic painkillers at emergency departments "underscores the deeply entrenched problem of racial and ethnic health care disparities in American medicine," Kate Scannell, a physician and syndicated columnist, writes in the

BioLineRx Ltd. (TASE:BLRX), a clinical stage drug development company, announced the presentation of data from pre-clinical trials of BL-1021 at the Isranalytica meeting 2008 held in Tel Aviv, Israel, on January 22-23, 2008. Recent pre-clinical trials demonstrated that BL-1021 was safe and effective in pre-clinical testing for the treatment of neuropathic pain.

The National Institute of Neurological Disorders and Stroke has awarded $1.7 million to University of Cincinnati (UC) anesthesiology researchers to study a condition that costs Americans $50 billion a year - low back pain.Back pain is the leading cause of disability in Americans younger than 45 years old and is experienced by 50 to 80 percent of adults at some point in their lives.

Mobile Anesthesiologists Holdings, LLC (Mobile) is pleased to announce the official release of Mobile Safe Anesthesia for Dentists or Mobile SAF-D?, a kinder, gentler approach in dental anesthesia. This new method provides deep sedation for short-duration, less complex dental cases requiring anesthesia, such as multiple fillings, crowns, extractions, and root canals.

Antidepressants might be worthless for treating low back pain, suggests a new review that found no evidence to support using the drugs in this way. Yet, up to 23 percent of U.S. physicians report prescribing antidepressants to patients with low back pain."The prescription of antidepressants as a treatment for back pain remains controversial," Donna Urquhart, Ph.D., research fellow at Monash University in Melbourne, Australia, and lead review author.

Today is not the first day of the rest of my life.  Yesterday was.  Check this out!!! Am having a new grandbaby and he/she is do on my 45th birthday.  Nope, nope, nope, not my first.  Actually my third grandchild.

 Was wondering if anyone has fibromyalgia.  Tis not a very nice thing to have.  I was diagnosed two years ago and have actually gotten worse.  The doctors have me on several drugs, some help and some do not.

My drug list is:  Neurontin 3 times a day, Zoloft once per day, Amitriptylene once per day.  Then, of course, when it gets bad, Darvacet, Flexeril and Ultram for pain and spasms.

Kind of really sucks.  Nothing is very much fun anymore cause everything hurts too much.  

Hey - I will be back tomorrow with more info on my struggle with this disease and how my family has reacted to this disease.